Northwest Biotherapeutics reported $8.13M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US USD 18.1M 809K
AstraZeneca AZN:LN USD 3.35B 280M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Celldex Therapeutics CLDX:US USD 6.53M 623K
Cti Biopharma CTIC:US USD 21.5M 92K
Cytori Therapeutics CYTX:US USD 2.22M 67K
Cytrx CYTR:US USD 51.91K 1.93M
Eisai 4523:JP JPY 88.08B 4.22B
Infinity Pharmaceuticals INFI:US USD 3.5M 6K
Merk MRK:US USD 2.49B 9M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Northwest Biotherapeutics NWBO:US USD 8.13M 199K
Pfizer PFE:US USD 4.87B 1.33B
Roche Holding ROG:VX 5.64B 899M